Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.10) by 360 percent. This is a 342.11 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $79.53 million which missed the analyst consensus estimate of $88.85 million by 10.50 percent. This is a 55.64 percent decrease over sales of $179.29 million the same period last year.